Product Specifications: Lyophilized Powder (>99% purity) in 3ml vial. *Requires Reconstitution ** Available for bulk custom order with 57 Cap/Crimp colors to choose from.
Application: Research bioregulator studied for cardiovascular health, anti-aging, and regenerative applications
Chemical Formula: C18H31N7O9
Molecular Weight: ~489.5 g/mol
Concentration: ≥99%
Cardiogen, in its peptide bioregulator form, is currently being investigated across three major research domains, focusing primarily on cardiovascular health, myocardial protection, and regenerative medicine applications.
Research Areas
1. Cardiovascular Health
Cardiogen research in cardiovascular health encompasses three main directions:
- Development of treatments for cardiovascular diseases
- Investigation of preventive measures for cardiovascular conditions
- Research into methods for improving overall cardiovascular function
2. Myocardial Protection
Studies on myocardial protection focus on:
- Strategies to reduce the severity of myocardial infarctions
- Methods to prevent cardiac remodeling following heart attacks
- Therapeutic approaches to improve cardiac function in patients with heart failure
3. Anti-Aging and Regenerative Medicine
The regenerative medicine applications being investigated include:
- Promotion of cellular regeneration and tissue repair mechanisms
- Enhancement of stem cell function and differentiation processes
- Development of treatments for age-related cardiovascular conditions
References:
Berg, D. D., Bohula, E. A., van Diepen, S., Katz, J. N., Alviar, C. L., Baird-Zars, V. M., Barnett, C. F., Barsness, G. W., Burke, J. A., Cremer, P. C., Cruz, J., Daniels, L. B., DeFilippis, A. P., Haleem, A., Hollenberg, S. M., Horowitz, J. M., Keller, N., Kontos, M. C., Lawler, P. R., ... Morrow, D. A. (2019). Epidemiology of shock in contemporary cardiac intensive care units. Circulation: Cardiovascular Quality and Outcomes, 12(3), e005618. https://doi.org/10.1161/CIRCOUTCOMES.119.005618
Tehrani, B. N., Truesdell, A. G., Sherwood, M. W., Desai, S., Tran, H. A., Epps, K. C., Singh, R., Psotka, M., Shah, P., Cooper, L. B., Rosner, C., Murphy, C. E., Flaherty, J. D., Sinha, S. S., deFilippi, C. R., Garan, A. R., & O'Connor, C. M. (2020). Standardized team-based care for cardiogenic shock. Journal of the American College of Cardiology, 76(13), 1617-1627. https://doi.org/10.1016/j.jacc.2020.08.001
Thiele, H., Ohman, E. M., de Waha-Thiele, S., Zeymer, U., & Desch, S. (2019). Management of cardiogenic shock complicating myocardial infarction: An update 2019. European Heart Journal, 40(32), 2671-2683. https://doi.org/10.1093/eurheartj/ehz363
Disclaimer: This product is intended solely for laboratory research purposes. It is not suitable for consumption by humans, nor for medical, veterinary, or household purposes. Researchers should handle all peptides with care and adhere to strict safety guidelines during experiments. Only qualified professionals with appropriate expertise should manage and handle this product. The distributor, manufacturer, and seller of this product are not responsible for misuse or any resulting consequences. By accessing this product, you consent to comply with these terms and conditions.
